Author:
Furlani D.,Klopsch C.,Gäbel R.,Ugurlucan M.,Pittermann E.,Klee D.,Wagner K.,Li W.,Wang W.,Ong L.L.,Nizze H.,Titze U.,Lützow K.,Lendlein A.,Steinhoff G.,Ma N.
Reference14 articles.
1. CIS3/SOCS3 suppresses EPO signalling by binding the EPO receptor and JAK2;Sasaki;J Biol Chem,2000
2. Recombinant human erythropoietin (rHuEPO): more than just the correction of uremic anemia;Buemi;J Nephrol,2002
3. Erythropoietin therapy for acute stroke is both safe and beneficial;Ehrenreich;Mol Med,2002
4. EPOetin alfa;Henry;Arch Intern Med,2004
5. Restoration of transforming growth factor beta signalling pathway in human prostate cancer cells suppresses tumorigenicity via induction of caspase-1-mediated apoptosis;Guo;Cancer Res,1999
Cited by
20 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献